Gene · 54
Papers2,683
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 2,683
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Effect of vitamin B1 supplementation on bone turnover markers in adults: an exploratory single-arm pilot study. | J Nutr Sci | 2025 | 40371216 | PubTator, text mining | PubMed |
| The clinical significance and potential therapeutic target of tumor-associated macrophage in non-small cell lung cancer. | Front Med (Lausanne) | 2025 | 40370720 | PubTator, text mining | PubMed |
| Bone Remodeling in Children with Acute Lymphoblastic Leukemia: A Two-Year Prospective Longitudinal Study. | Int J Mol Sci | 2025 | 40362542 | PubTator, text mining | PubMed |
| Family mapping of previously identified patients with pathogenic or likely pathogenic ALPL variants using predictive genotyping and detailed phenotyping approach: the FAME case-control study. | JBMR Plus | 2025 | 40224914 | PubTator, text mining | PubMed |
| Laboratory-based Biomarkers for Risk Prediction, Auxiliary Diagnosis and Post-operative Follow-up of Osteoporotic Fractures. | Curr Osteoporos Rep | 2025 | 40199776 | PubTator, text mining | PubMed |
| Mild antiresorptive activity of an anti-vascular endothelial growth factor A antibody and sunitinib in a rat model of bone resorption. | Bone Rep | 2025 | 40177629 | PubTator, text mining | PubMed |
Update on the role of bone turnover markers in the diagnosis and management of osteoporosis: a consensus paper from The European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO), International Osteoporosis Foundation (IOF), and International Federation of Clinical Chemistry and Laboratory Medicine (IFCC). | Osteoporos Int | 2025 | 40152990 | PubTator, text mining | PubMed |
| Predictive Factors for Increased Bone Density Following Romosozumab Administration Based on Pre-Administration Blood Test Results. | Yonsei Med J | 2025 | 40134082 | PubTator, text mining | PubMed |
| Severe denosumab-induced hypocalcemia requiring long-term intensified medication in a patient with EGFR-mutant lung cancer and diffuse osteoblastic bone metastases. | Respir Med Case Rep | 2025 | 40104434 | PubTator, text mining | PubMed |
| Bone turnover markers as predictors of hypocalcemia in patients with bone metastases receiving denosumab. | JBMR Plus | 2025 | 40098983 | PubTator, text mining | PubMed |
| Abstracts of the 35th Meeting of the German Society for Pediatric and Adolescents Rheumatology (Gesellschaft für Kinder- und Jugendrheumatology (GKJR). | Pediatr Rheumatol Online J | 2025 | 40098132 | PubTator, text mining | PubMed |
| The regulatory role of ACP5 in the diesel exhaust particle-induced AHR inflammatory signaling pathway in a human bronchial epithelial cell line. | Sci Rep | 2025 | 40087344 | PubTator, text mining | PubMed |
| Arcyriaflavin A Alleviates Osteoporosis by Suppressing RANKL-Induced Osteoclastogenesis. | Int J Mol Sci | 2025 | 40076762 | PubTator, text mining | PubMed |
| TRAPping the effects of tobacco smoking: the regulation and function of Acp5 expression in lung macrophages. | Am J Physiol Lung Cell Mol Physiol | 2025 | 39993028 | PubTator, text mining | PubMed |
| Isonardosinone attenuates osteoclastogenesis and OVX-induced bone loss via the MAPK/NF-κB pathway. | Toxicol Appl Pharmacol | 2025 | 39956462 | PubTator, text mining | PubMed |
| Microplastics in human skeletal tissues: Presence, distribution and health implications. | Environ Int | 2025 | 39946929 | PubTator, text mining | PubMed |
| Effect of nanoemulsion carbonated hydroxyapatite-statin administration on Acp 5 and Runx-2 expression during orthodontic relapse in rats. | J Oral Biol Craniofac Res | 2025 | 39866381 | PubTator, text mining | PubMed |
| Evaluation of Bone Mineral Metabolism in Pre-Dialysis Chronic Kidney Disease: Quantitative Computed Tomography vs. Dual-Energy Absorptiometry and Correlation with Bone Turnover Markers. | Medicina (Kaunas) | 2025 | 39859133 | PubTator, text mining | PubMed |
| Clinical, laboratory, and molecular characteristics of patients with spondyloenchondrodysplasia: a case series study. | Eur J Pediatr | 2025 | 39853520 | PubTator, text mining | PubMed |
| Real-world safety and effectiveness of romosozumab following daily or weekly administration of teriparatide in primary and secondary osteoporosis. | Bone | 2025 | 39826700 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/54/papers?page=8